Cybin Inc - Asset Resilience Ratio

Latest as of December 2022: 0.21%

Cybin Inc (CYBN) has an Asset Resilience Ratio of 0.21% as of December 2022. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

CA$125.00K

≈ $90.42K USD Cash + Short-term Investments

Total Assets

CA$60.69 Million

≈ $43.91 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (None–None)

This chart shows how Cybin Inc's Asset Resilience Ratio has changed over time. Check how strategically is Cybin Inc's equity deployed to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Cybin Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Cybin Inc stock valuation.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CA$0.00	0%
Short-term Investments	CA$125.00K	0.21%
Total Liquid Assets	CA$125.00K	0.21%

Asset Resilience Insights

Limited Liquidity: Cybin Inc maintains only 0.21% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Cybin Inc Industry Peers by Asset Resilience Ratio

Compare Cybin Inc's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Tubize-Fin BR:TUB	Biotechnology	0.05%
Verona Pharma plc F:I9SA	Biotechnology	0.00%
Xiamen Amoytop Biotech Co Ltd SHG:688278	Biotechnology	4.69%
Syndax Pharmaceuticals Inc NASDAQ:SNDX	Biotechnology	46.79%
Neuren Pharmaceuticals Ltd AU:NEU	Biotechnology	90.43%
Vor Biopharma Inc NASDAQ:VOR	Biotechnology	63.47%
Chengdu Kanghua Biological Products SHE:300841	Biotechnology	1.19%
Jiangsu Aidea Pharmaceutical Co Ltd SHG:688488	Biotechnology	4.35%

Annual Asset Resilience Ratio for Cybin Inc (None–None)

The table below shows the annual Asset Resilience Ratio data for Cybin Inc.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
No yearly data available.

pp = percentage points

About Cybin Inc

NEO:CYBN Canada Biotechnology

Market Cap

$301.37 Million

CA$416.62 Million CAD

Market Cap Rank

#14743 Global

#440 in Canada

Share Price

CA$8.35

Change (1 day)

-27.89%

52-Week Range

CA$7.70 - CA$11.99

All Time High

CA$150.86